A spatiotemporally controlled MNE@PDA-Diz/GP hydrogel system: enhancing spinal cord injury repair via ROS scavenging, calcium influx inhibition, and macrophage polarization.

阅读:1
作者:Bao Xin, Sun Jingyan, Gao Xing, Xu Mingsheng, Dong Chen, Pan Honghua
Spinal cord injury (SCI) is a severe type of central nervous system trauma. It not only causes the loss of sensory and motor function but also triggers a series of secondary injuries, especially oxidative stress and inflammation. Current therapeutic methods fail to effectively address the multi-pathological cascade reactions, highlighting an urgent need for integrated treatment strategies that can simultaneously repair the damaged microenvironment and promote neural regeneration. In this study, a multifunctional thermosensitive MNE@PDA-Diz/GP hydrogel was designed. We incorporated a core-shell structured manganese nanozyme@polydopamine (MNE@PDA), modified with dizocilpine, into gelatin methacryloyl and a poly(N-isopropylacrylamide) hydrogel (GP hydrogel), featuring a thermosensitive polymer. The MNE@PDA-Diz/GP hydrogel, which was crosslinked under UV-vis light, provides a biocompatible three-dimensional scaffold that mimics the natural mechanical properties of the spinal cord, thereby supporting cell adhesion and proliferation. Meanwhile, the photothermal properties of polydopamine and the thermosensitivity of poly(N-isopropylacrylamide) enable spatiotemporally controlled release of dizocilpine. These three components work in synergy: the manganese nanozyme scavenges reactive oxygen species to exert anti-oxidative effects, polydopamine modulates macrophage polarization to alleviate inflammation, and dizocilpine inhibits calcium influx to provide neuroprotection. This work presents a novel and versatile platform for multi-targeted SCI therapy and promotes the development of regenerative strategies.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。